PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Por um escritor misterioso
Descrição
Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Hypertriglyceridemia: Practice Essentials, Pathophysiology, Etiology
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials
Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations: Molecular Therapy
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review
Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress
Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle‐related side‐effects - Sivashanmugarajah - 2019 - Internal Medicine Journal - Wiley Online Library
Myopathy with statin–fibrate combination therapy: clinical considerations
Differential Between Self-Limited Statin Myopathy and Statin-Associated
PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Novel potassium binders: a clinical update
de
por adulto (o preço varia de acordo com o tamanho do grupo)
